Cargando…

Scalp high‐frequency oscillations differentiate neonates with seizures from healthy neonates

OBJECTIVE: We aimed to investigate (1) whether an automated detector can capture scalp high‐frequency oscillations (HFO) in neonates and (2) whether scalp HFO rates can differentiate neonates with seizures from healthy neonates. METHODS: We considered 20 neonates with EEG‐confirmed seizures and four...

Descripción completa

Detalles Bibliográficos
Autores principales: Cserpan, Dorottya, Guidi, Greta, Alessandri, Beatrice, Fedele, Tommaso, Rüegger, Andrea, Pisani, Francesco, Sarnthein, Johannes, Ramantani, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690668/
https://www.ncbi.nlm.nih.gov/pubmed/37702021
http://dx.doi.org/10.1002/epi4.12827
Descripción
Sumario:OBJECTIVE: We aimed to investigate (1) whether an automated detector can capture scalp high‐frequency oscillations (HFO) in neonates and (2) whether scalp HFO rates can differentiate neonates with seizures from healthy neonates. METHODS: We considered 20 neonates with EEG‐confirmed seizures and four healthy neonates. We applied a previously validated automated HFO detector to determine scalp HFO rates in quiet sleep. RESULTS: Etiology in neonates with seizures included hypoxic‐ischemic encephalopathy in 11 cases, structural vascular lesions in 6, and genetic causes in 3. The HFO rates were significantly higher in neonates with seizures (0.098 ± 0.091 HFO/min) than in healthy neonates (0.038 ± 0.025 HFO/min; P = 0.02) with a Hedge's g value of 0.68 indicating a medium effect size. The HFO rate of 0.1 HFO/min/ch yielded the highest Youden index in discriminating neonates with seizures from healthy neonates. In neonates with seizures, etiology, status epilepticus, EEG background activity, and seizure patterns did not significantly impact HFO rates. SIGNIFICANCE: Neonatal scalp HFO can be detected automatically and differentiate neonates with seizures from healthy neonates. Our observations have significant implications for neuromonitoring in neonates. This is the first step in establishing neonatal HFO as a biomarker for neonatal seizures.